Hexavibex en es it fr

Hexavibex Brand names, Hexavibex Analogs

Hexavibex Brand Names Mixture

  • No information avaliable

Hexavibex Chemical_Formula


Hexavibex RX_link

No information avaliable

Hexavibex fda sheet

Hexavibex msds (material safety sheet)

Hexavibex MSDS

Hexavibex Synthesis Reference

No information avaliable

Hexavibex Molecular Weight

169.178 g/mol

Hexavibex Melting Point

207 oC

Hexavibex H2O Solubility

2.2E+005 mg/L

Hexavibex State


Hexavibex LogP


Hexavibex Dosage Forms


Hexavibex Indication

For the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy.

Hexavibex Pharmacology

Vitamin B6 (pyridoxine) is a water-soluble vitamin used in the prophylaxis and treatment of vitamin B6 deficiency and peripheral neuropathy in those receiving isoniazid (isonicotinic acid hydrazide, INH). Vitamin B6 has been found to lower systolic and diastolic blood pressure in a small group of subjects with essential hypertension. Hypertension is another risk factor for atherosclerosis and coronary heart disease. Another study showed pyridoxine hydrochloride to inhibit ADP- or epinephrine-induced platelet aggregation and to lower total cholesterol levels and increase HDL-cholesterol levels, again in a small group of subjects. Vitamin B6, in the form of pyridoxal 5'-phosphate, was found to protect vascular endothelial cells in culture from injury by activated platelets. Endothelial injury and dysfunction are critical initiating events in the pathogenesis of atherosclerosis. Human studies have demonstrated that vitamin B6 deficiency affects cellular and humoral responses of the immune system. Vitamin B6 deficiency results in altered lymphocyte differentiation and maturation, reduced delayed-type hypersensitivity (DTH) responses, impaired antibody production, decreased lymphocyte proliferation and decreased interleukin (IL)-2 production, among other immunologic activities.

Hexavibex Absorption

Readily absorbed

Hexavibex side effects and Toxicity

Oral Rat LD50 = 4 gm/kg. Toxic effects include convulsions, dyspnea, hypermotility, diarrhea, ataxia and muscle weakness.

Hexavibex Patient Information

No information avaliable

Hexavibex Organisms Affected

Humans and other mammals